# RIFAXIMIN
> **ANDA214369** · Abbreviated New Drug Application (Generic) · Sponsor: NORWICH PHARMACEUTICALS INC · Approved 2024-06-20
## Drug
- **FDA Application Number:** ANDA214369
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIFAXIMIN
- **Generic name:** Rifaximin
- **Active ingredients:** RIFAXIMIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** NORWICH PHARMACEUTICALS INC
- **First approval:** 2024-06-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214369)
---
*AI Analytics · CC0 1.0*